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Abstract
Background: Untreated mental health problems may result in poor outcomes for youth with systemic lupus
erythematosus (SLE) and mixed connective tissue disease (MCTD). We investigated perceptions, barriers and
facilitators for mental healthcare of these youth.
Methods: We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, ages 11–22 years,
and their parents. We used purposive sampling to deliberately obtain the experiences of youth screened during a
previous study for depression and anxiety with the Patient Health Questionnaire 9 and the Screen for Childhood
Anxiety and Related Disorders, respectively. We recruited 6 youth with previous positive screens and 10 with
negative screens. We assessed interim mental health history, and qualitatively examined perceptions, barriers and
facilitators for mental healthcare.
Results: Youth with a mental health history increased from 6 (38 %) at initial screening to 9 (56 %) at interview
(mean follow-up = 2.1 years). Youth receiving mental health treatment increased from 33 to 67 %. Youth and
parents identified rheumatologists as primary physicians and found mental health screening in rheumatology
acceptable. Barriers to mental healthcare included: stigma; fear; uncertainty about getting help; parental
emotional burden; minimization by doctors; and limited mental healthcare access. Facilitators included: strong
clinician relationships; clinician initiative, sincerity and normalization in discussing mental health; and increased
patient/family awareness of mental health issues in SLE/MCTD.
Conclusion: Youth with SLE/MCTD and their parents perceive pediatric rheumatologists as a preferred source for
mental health screening, guidance and referral. Interventions addressing barriers and enhancing facilitators may
improve mental healthcare for youth with SLE/MCTD.
Keywords: Pediatric rheumatology, Lupus, Mixed connective tissue disease, Depression, Anxiety
Background
Systemic lupus erythematosus (SLE) and the SLE-like syn-
drome of mixed connective tissue disease (MCTD) are
chronic autoimmune conditions associated with significant
morbidity and mortality due to multi-organ damage and
side effects of long-term, high-risk immunosuppressive
treatment [1]. Mental health problems such as depression
and anxiety are common in youth with SLE [2–4] and are
under-recognized and undertreated [5]. In contrast to the
prevalence of depression at 11 % and anxiety at 8 % of the
United States general adolescent population [6, 7], these
disorders occur in 20–55 % and 20–35 %, respectively, of
youth with SLE/MCTD [2, 5, 8]. While the cause remains
unclear, potential reasons include CNS inflammation [9],
the psychological burden of chronic disease, effects of ster-
oid treatment, social, cultural and genetic factors. Mental
health intervention is important because depression and
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anxiety are associated with poor clinical and psychosocial
outcomes in adults with SLE [10–12], as well as youth with
other chronic diseases [13–15].
The US Preventive Services Task Force recommends
depression screening for adolescents when systems of
care are in place to ensure accurate diagnosis and treat-
ment [16]. In primary care, studies indicate that collab-
orative mental and medical care models effectively
connect affected youth to mental health services [17].
However, these systems may miss youth such as those
with SLE who primarily rely on subspecialty care and
may benefit from mental health intervention in subspe-
cialty settings. In a previous cross-sectional survey study
examining the prevalence of depression and anxiety and
their association with healthcare utilization in youth
with SLE/MCTD, we found that those with depression
were less likely to visit their primary care doctor than
those without depression, but they were equally as likely
to visit their rheumatologist [5]. Rheumatologists may
therefore have a central role in intervention for affected
youth with SLE/MCTD, but it is unknown whether these
youth and their parents would find this acceptable.
In this qualitative analysis we sought to explore patient
and parent perspectives on mental healthcare for youth
with SLE/MCTD. Qualitative methods use a systematic
approach to analyzing empirical information, and are a
valuable tool for understanding complex, real-world
phenomena such as patient experiences with aspects of
healthcare [18]. Purposive sampling, often used in quali-
tative methods, involves non-random, deliberate sam-
pling from pre-defined groups to maximize collection of
relevant data [19]. To gain insight on the mental health-
care experience of youth with SLE/MCTD, we recruited
a purposive sample of these youth and their parents who
had participated in depression and anxiety screening
during our previous study. We aimed to: 1) qualitatively
characterize their beliefs about mental health and per-
ceived barriers and facilitators to mental healthcare, and
2) assess rates of interim depression, anxiety and mental
health treatment in youth with SLE/MCTD.
Methods
Setting
The study was conducted from July 2014 to April 2015
at The Children’s Hospital of Philadelphia (CHOP) Div-
ision of Rheumatology, which serves an annual volume
of approximately 100 adolescents with SLE/MCTD, and
was staffed by 13 physicians, 3 nurses and 1 social
worker during the study period.
Participants
We recruited 16 pairs of youth and their parents
(or legal guardians). Youth were eligible for inclusion if
they: 1) had a diagnosis of SLE (fulfilling ≥4 of 11 SLE
classification criteria) [20] or MCTD (fulfilling either
Kahn’s or Alarcon-Segovia’s criteria) [21] with pediatric-
onset before the 18th birthday; 2) were ages 8 years and
above, and; 3) had participated in a previous cross-
sectional study of depression and anxiety in pediatric SLE/
MCTD [5]. Parents of eligible youth were eligible for
inclusion. All 50 youth-parent dyads in the previous study
were invited to participate in-person, by phone, mail or
email; 16 dyads accepted, 33 declined and one was
deemed ineligible due to co-occurring developmental dis-
order (Fig. 1).
Data collection and analysis
We conducted a semi-structured individual interview
with each of the 16 youth and 16 parents, during which
open-ended questions were followed by specific prompts
to elicit perceptions, barriers and facilitators for both
identification and treatment of mental health problems.
An interviewer trained in qualitative techniques and not
involved in patient care administered separate interview
guides for youth and parents containing the questions
and prompts. Interviews took place in-person (n = 13) at
the CHOP rheumatology clinic or via telephone (n = 19).
Telephone interviews were offered to maximize avail-
ability for participation; they have been shown to yield
comparable content to in-person interviews in children
[22], and have benefits for increasing perceived subject
anonymity during discussion of sensitive health topics
[23]. All interviews were digitally recorded, transcribed,
de-identified and entered into NVivo software (QSR
International Pty Ltd., Version 10, 2014). We conducted
thematic analysis of the textual data to identify common
themes or patterns across participants pertaining to
mental health care. Using an integrated approach we
sorted data into broad subject areas by assigning “codes”
to specific transcript comments, utilizing both a priori
codes that reflected our key research question alongside
inductive codes that emerged from the data themselves
[18]. Each interview was coded separately in NVivo by
two researchers; all coded text was compared to ensure
consistency and revised after each session consistent
with the constant comparative method [24]. Analysis for
underlying themes was performed concurrent with cod-
ing. A narrative summary was generated to include illus-
trative quotes.
Demographic and disease characteristics
To characterize our study cohort, we integrated our
qualitative data with subject demographic and disease
attributes obtained from a REDCap database from the
previous study as well as interim data from the elec-
tronic medical record. Attributes included: age; gender;
race/ethnicity; highest household education level; disease
duration; and mental health status.
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We determined mental health status based on the re-
sults of mental health screening during the previous
study and interim events between the previous study
and the interview (per subject report or medical record).
A mental health history was defined as the presence of
positive screen for depression or anxiety symptoms
during the previous study and/or interim mental health
referral and/or treatment. In the previous study, the
Patient Health Questionnaire-9 (PHQ-9), a validated 9-
item self-administered module [25], was used to screen
for depression; the Screen for Childhood Anxiety Re-
lated Disorders (SCARED), a validated self-administered
41-item module [26], was used to screen for anxiety
symptoms. A positive depression screen was defined as a
score ≥5 on the PHQ-9 and included scores in the mild
(5–9), moderate (10–14), moderately severe (15–19) and
severe (20–27) ranges [27]. We included scores in the
mild range because persistent symptoms, regardless of
severity, convey an increased risk for later development
of major depression and suicidal behavior [28–30]. A
score of ≥1 on item 9 of the PHQ-9 questionnaire was
considered indicative of suicidal ideation and also con-
sidered a positive depression screen regardless of total
PHQ-9 score. A positive anxiety screen was defined as a
score totaling ≥25 on the SCARED. Depression and
anxiety screening was performed during outpatient
rheumatology visits using REDCap (Research Electronic
Data Capture) electronic survey and data capture tools
hosted at CHOP [31]. Upon identification of depression
or anxiety symptoms, an educational handout was pro-
vided to the family with mental healthcare referral infor-
mation. Identified suicide risk was addressed with a
suicide prevention protocol consisting of immediate dir-
ect questioning of suicidal intent, plan or attempt within
the prior week; endorsement of any of these prompted
development of a safety plan and urgent referral for im-
mediate psychology/psychiatry evaluation.
We assessed the similarity of demographic and disease
characteristics between the 16 participating and 34 non-
participating dyads from the previous study. Chi-square
tests were used for categorical data and Mann–Whitney
tests were used for continuous data. Participating dyads
Current Study:  
N=16  
 youth-parent dyads 





Screening of youth for 
depression (PHQ-9) 
and anxiety (SCARED)  
33 youth 
screened (-) 
1 dyad ineligible 
10 dyads declined 
1 not interested 
2 unable to schedule 





Dyads invited to 
participate in 
current study 
Follow-up interviews & 
assessment of interim 
mental health history 
23 dyads declined 
6 not interested 
2 unable to schedule 
15 did not respond 
Fig. 1 Flow diagram of sampling and participation in the study. Shown is the purposive sampling strategy utilized to recruit youth with SLE/
MCTD and their parents for participation in the interview study. Youth-parent dyads who had participated in a previous cross-sectional study,
during which youth were screened for depression and anxiety, were invited to participate. Sixteen dyads accepted and underwent interviews and
assessment of their interim mental health history. Of the 33 dyads declining to participate, 7 were not interested, 4 expressed interest but were
not successfully scheduled for interview (all were followed at CHOP rheumatology but 3 were away at college), and 22 did not respond (7 were
no longer followed at CHOP; 8 were followed at CHOP but were away at college). One dyad was deemed ineligible due to co-occurring
developmental disorder
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were similar to the non-participating dyads, except for
significantly shorter disease duration.
Ethics, consent and permissions
Informed parental consent and child assent for study
participation and publication of individual data was ob-
tained prior to all interviews. The study was approved by
the CHOP Institutional Review Board.
Results
For the 16 youth-parent pairs, the follow-up time between
participation in the previous study and interviews ranged
between 1.5 and 2.5 years (mean = 2.1 years, SD = 0.3).
Subject characteristics are presented in Table 1. The
results for perceptions of mental health and screening and
barriers/facilitators to mental healthcare are summarized
below, with illustrative quotes in Tables 2 and 3, respect-
ively. Youth with a history of mental health symptoms in-
creased from 6 (38 %) at initial screening to 9 (56 %) at
follow-up interview; the symptom and treatment status of
these youth are summarized in Table 4.
Perceptions of mental health & screening in the
rheumatology setting
Almost all youth and parents placed equal importance
on emotional and physical health. Many described an
interaction and reliance between these two (Table 2).
Some participants also noted a link between a stressed
Table 1 Demographic characteristics of participating youth with SLE/MCTD and non-participants
Participants Non-participants p-value
N = 16 N = 34
Age of youth in years, mean (SD)
At initial survey 15.0 (3.4) 15.8 (2.8) 0.25
At interview 17.0 (3.6) – –
Female gender of youth, N (%) 13 (81) 30 (88) 0.51
Female gender of parent, N (%) 11 (69) – –
Race/ethnicity of youtha, N (%) 0.60
White 10 (63) 14 (41)
Black 4 (25) 14 (41)
Asian 1 (6) 2 (6)
Hispanic/Latino 1 (6) 2 (6)
Other 0 (0) 2 (6)
Highest household education levelb, N (%) 0.14
Less than college 1 (6) 8 (24)
College and above 15 (94) 26 (76)
Disease duration of youth in years, median (IQR)
At initial survey 0.9 (0.3, 2.9) 2.9 (1.3, 4.8) 0.01
At interview 3.0 (2.4, 5.0) – –
Initial positive mental health screen in youthb, N (%) 6 (38) 11 (32) 0.72
Depression 4 (25) 6 (18) 0.54
Suicidal ideation 4 (25) 3 (9) 0.12
Anxiety 5 (31) 6 (18) 0.28
Years between initial survey and interview, mean (SD) 2.1 (0.3) – –
Presence of mental health historyc in youth at interview, N (%) 9 (56) – –
Depression 6 (38) – –
Suicidal ideation 5 (31) – –
Anxiety 8 (50) – –
aRace/ethnicity was categorized into as the mutually exclusive groups; other includes American Indian/Alaska Native, Native Hawaiian/Pacific Islander and other)
bData for these variables was obtained at time of the previous study. Highest household education level was categorized as either 1) less than college (includes
incomplete college or less) or 2) college (includes completed associate, bachelors or advanced degree) and above. A positive depression screen was defined as a
score ≥5 on the PHQ-9. A score of ≥1 on item 9 of the PHQ-9 questionnaire was considered indicative of suicidal ideation and also considered a positive depression
screen regardless of total PHQ-9 score. A positive anxiety screen was defined as a score totaling ≥25 on the SCARED
cA mental health history was defined as the presence of depression or anxiety symptoms at the time of screening for the previous study and/ or mental health
referral and/or treatment (per subject report or medical record) in the interim between the previous study and the interview
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emotional state and subsequent lupus flare. Most youth
reacted positively to being asked about emotions on the
electronic PHQ-9 and SCARED screening question-
naires in the previous study (Table 2). Most felt at ease
with the content of the questions, the electronic mode
and administration in the rheumatology setting. Some
felt that the screening questions helped them to become
more aware of their emotions. A few reported feeling
valued as a patient: “I feel that I’m not really always
comfortable with telling random people how I feel, how
my day went and everything. But it makes me feel like
I’m important.” (17 year-old female). Another youth
reported positive reinforcement of her healthy emotional
state. Despite these positive reactions, some youth felt
awkward, uncomfortable and vulnerable with being
asked about their mental health. A few adolescents
expressed a desire to conceal their true emotions. Two
admitted to not answering the questions honestly.
Reactions of parents to assessment of their child’s
emotional status in the rheumatology setting were also
mostly positive. Eleven (69 %) said that the survey was
Table 2 Illustrative quotes for perceptions of mental health &
screening for youth with SLE/MCTD
Mental health
“When you feel good in your mind and you have confidence and you’re
feeling able to do things, and then you can physically do it, it just makes
you a happier… Mind, body, soul kind of thing…it all needs to jive. You
could have a great body image, but maybe you’re depressed about
something else in your life and that kind of makes your body not feel so
great and then that’s all very connected.” Parent
“So having a good social life, that’s pretty important to be healthy. And
even though maybe I’m not physically–like physically the best, like having
good social and mental could make up for that…” 16 y/o male
“I think your mind has a lot to do with it…having a lot of your, so to
speak, mental health taken care of, actually can help improve your physical
health, as well. It’s equally important.” 19 y/o female
“Essentially with lupus, a lot of the–maybe even the original time, the lupus
attack and the damage done to my kidneys was based on stress possibly.
So that’s a big part of making sure I keep healthy and not being stressed
out or letting things hang over my head.” 18 y/o male
Screening in the Rheumatology Setting
“It was helpful for me to realize, because sometimes I’ll think, oh I’m just
feeling up or down, like happy or sad. But really asking, do you feel scared,
do you feel anxious, do you feel like this kind of sad, that kind of sad, that
was interesting. And that sort of made me think about it a little be more.”
18 y/o female
“It was kind of almost reassuring knowing I could answer all those
questions without having to say I’m stressed out or anything like that, and
that everything was going good and the satisfaction with what was going
on.” 18 y/o male
“They were easy questions, pretty flat out, but I don’t know if I exactly told
the truth, but I don’t know.” 14 y/o female
“I feel like it was personalized, but not in a bad way, the kind of way that
it was like, do they see something in me that someone else isn’t catching,
or is it–like is it written across my face that I’m worried. I didn’t feel
attacked. I just felt like I wasn’t doing as good of a job as I thought I was
at hiding it.” 19 year-old female
Table 3 Illustrative quotes for barriers & facilitators to mental
healthcare for youth with SLE/MCTD
Barriers
1) Stigma
“You see it a lot today with mental health being a bit of a taboo. It’s not
really something that people like to talk about… because you think it’ll go
away or you’re exaggerating. So it’s not really an easy topic.” 19 y/o female
“I don’t want to disclose who am I when I want to take counseling.” Parent
2) Fear
“I don’t think I was fully honest, because I was so anxious and nervous…I
think it was just my nerves and not wanting to talk about it because it
was so scary.” 19 y/o female
3) Uncertainty about getting help
“And I think it’s probably a beneficial thing, but I wouldn’t even know
where to start looking.” Parent“She wasn’t sharing because she didn’t know
what to do. She didn’t know how to get back on target.” Parent
4) Parental emotional burden
“I didn’t realize until she told me … that she was actually hiding all that
stuff … because I think she thought it was too much for me to handle.”
Parent
“I think if their social liaisons were able to…provide you with some support
groups…the opportunity for yourself to see a therapist or a specialist who
can help you counsel your child, I think that would be most beneficial.”
Parent
5) Minimization by medical doctors
“Well, she mainly gave me pamphlets that had sort of deep breathing
exercises and while that helped somewhat, what I needed was more
therapy and that’s when I started seeing a psychologist for cognitive brain
therapy and that was more what I needed, as opposed to meditative
exercises.” 18 y/o female
6) Poor access to mental health professionals
“The difficulty, really, is… the finance, the co-pays are frequent right now.”
Parent
“It was difficult…we had to travel [far]…there weren’t any pediatric
psychiatrists [nearby].” Parent
“It’s a little further away than I would like it to be due to gas prices” Parent
“We would schedule the next [appointment] based on, of course, my ability
to take her because I had to go to work, and we still hadn’t had our own
vehicle yet.” Parent
Facilitators
1) Strong clinician relationship
“I probably would not talk to the primary care just because we don’t have
a relationship with him yet. It would start with the rheumatologist.” Parent
2) Clinician initiative to discuss mental health
“My first rheumatologist…recommended it. Because of what I have, he
thought it was stress related. So I, fortunately, didn’t have to bring it up.”
16 y/o male
“He would say teenage girls have a lot going on…sometimes you can’t say
things to mom…it helps to have that unbiased sounding board to just
knock things off of.” Parent
3) Clinician sincerity
“It’s like you could tell that they really cared about your well-being. Some-
times you can tell if it’s more protocol than they really care, but it seemed
like they genuinely cared about how you felt so that they could treat you
better. And it just felt good.” 12 y/o female
4) Normalization of mental health issues
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“on target” or “was fine”, while the rest of the parents
had no specific comments. All parents thought that this
information was appropriate for their rheumatologist to
know and thought it to be in line with their previous
experience completing similar items on intake question-
naires at the PCP and rheumatology clinics. Some per-
ceived that the mere asking of the questions indicated
that their physicians cared more about their child, in-
creased their awareness of their child’s emotions, and
made them feel more comfortable to mention any emo-
tional concerns. A few parents were grateful, stating that
they had never been asked about their child’s emotions.
One parent urged doctors to ask about mental health
saying, “Just ask. Don’t be afraid to ask. Don’t be shy
even if things look like it’s okay.” Some concerns, how-
ever, were raised about potentially overwhelming their
child if the timing of the assessment was too close to
diagnosis.
Barriers and facilitators for discussing mental health
concerns
We found several barriers and facilitators for youth in
presenting their mental health concerns (Table 3). Youth
most commonly indicated a parent as the first person
that they would communicate with about emotions such
as sadness and worry, followed by friends and other rela-
tives. Parents also identified themselves as the natural
initial contact for their child’s expression of stress, sad-
ness or worry. Some described a pro-active approach by
regularly checking in about their child’s feelings. Others,
however, expressed feeling ill-equipped and unable to
help with their child’s observed emotions due to their
own emotional burden and lack of knowing how to ap-
proach the issue.
Almost all parents said that they would feel comfort-
able bringing concerns about their child’s mental health
to the rheumatologist, whom they viewed as the primary
doctor for their children. Reasons for this included
awareness of an association of mental health problems
with lupus, trust and confidence in the therapeutic rela-
tionship. Most parents also felt comfortable discussing
concerns with the PCP for the latter reason; those who
felt uncomfortable indicated a lack of established and
trusted relationship with the PCP usually due to lack of
continuity. One parent reported discussing mental
health with another subspecialist who was viewed as the
primary doctor.
In contrast, few youth said they would take the initia-
tive to mention their feelings to their doctors. Of those
who did, all said they would talk to their rheumatologist,
and fewer to their PCP. Reasons for youth not mention-
ing emotions to doctors included: discomfort with talk-
ing about their emotions, worry about what their
parents and others would think, uncertainty about what
would happen, lack of awareness that emotions could be
related to SLE/MCTD, and perceived disinterest of the
doctor. Thus having an established relationship and
accepting environment seemed to be a prerequisite for
feeling comfortable enough to discuss mental health
concerns. Adolescents with experience talking to doctors
about their emotions were appreciative of having an
opportunity to discuss their emotions and stress. They
reported feeling validated and secure after talking to
their physicians. Learning that sadness and worry were
commonly experienced by other kids with SLE/MCTD
helped to “normalize” their emotional experience:
“When I talk to my rheumatologist…even if it’s not med-
ical at all, he says…this could be causing stress, which
has been really helpful to know that it’s a normal thing.”
(18 y/o female) Some wished to be able to discuss emo-
tional concerns with their doctors in between visits.
Others reported that their concerns were minimized by
doctors, with lack of exploration and recognition of
symptom severity, and recommendation for ineffective
intervention.
Barriers and facilitators for mental health treatment
We identified barriers and facilitators (Table 3) to treat-
ment for the nine youth with a mental health history
(Table 4). Of the six youth screening positive and re-
ferred for mental health evaluation in the initial study,
two were already receiving mental health treatment, two
subsequently obtained treatment by the time of inter-
view, and two did not seek treatment. Of the three youth
with a newly identified mental health problem in the in-
terim, one had an inpatient psychiatric hospitalization,
one was referred but not receiving treatment, and one
sought treatment on her own. Almost all parents of
youth with symptoms acknowledged the importance of
care by a mental health professional for their children,
but they stated that initially knowing where to get help
was difficult, and were appreciative of efforts made by
their doctors. One symptomatic youth and her mother
described delay in mental healthcare due to minimization
Table 3 Illustrative quotes for barriers & facilitators to mental
healthcare for youth with SLE/MCTD (Continued)
“Asking these things and thinking about them, and it should just be a
normal thing. It shouldn’t be sort of weird or lie or–just part of routine.”
Parent
“It’s after that first initial time, mentioning it, that it’s like not a problem, it’s
an easy topic to talk about. Especially when they’re willing to help.” 18 y/o
female
“You don’t have to be crazy or extremely naughty to have to use a
therapist…it’s good to make it seem perfectly acceptable and fine and
normal to talk to somebody in the mental health field. Because the last
thing you want is a kid getting more and more depressed and keeping it
in, not being able to have somebody to talk to.” Parent
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Table 4 Symptom and treatment status of youth with SLE/MCTD and a mental health history (N = 9)





Anxiety Referred at initial study; did not seek further evaluation or
treatment; symptoms resolved (2.0 years)
“I really thought that it had to do with her health…so I figured
if we got the health straightened out, the rest of it would work
itself out, which it did. We didn’t really address it…. She was







Referred at initial study; in weekly sessions with school
counselor; persistent depression & anxiety (2.2 years)
“I have anxiety issues…I went to my counselor and then I went
to my mom and they both agreed and so that’s where I went.”
Youth
“We found it on our own. They offered it at school and we
thought it would be good for her… It was free.” Parent
17 y/o
Female
Anxiety Referred at initial study; persistent anxiety, new depression;
PCP manages psychotropic medication; receives counseling
through social worker at school (2.1 years)
“First, I was having anxiety and anxiety attacks…and I think I’d
been having bouts of depression for a while and just, kind of,
didn’t realize it and pushed it under the rug…when I came to
terms with it, I got on medicine that’s really helping, and just
being more open about it helps a lot… I also have a social
worker at school that I talk to.” Youth
“We went in and talked to [the pediatrician] and brought it up
to her, and that’s when she put her on medication…definitely
something that she needed…she talks to the social worker at
school, and I’ve always asked her, do you need to talk to
somebody else, and at this point she doesn’t feel like she needs






Referred at initial study; did not seek further evaluation or
treatment; persistent depression (1.6 years)
“Sometimes I feel sad, like really sad …sometimes I just don’t
feel comfortable talking about that, to anyone…[my
rheumatologist] did recommend a psychologist, but I was like, I







In treatment at initial study; discontinued psychiatric
medications and stopped seeing therapist by time of
interview; persistent depression & anxiety (2.3 years)
“I pulled myself off of my medication for my 17th birthday…I
wanted to [to go back to therapy]…I just never got around to
it.” Youth
“Currently, I would say she’s doing better, but she does have her
own anxieties …and depression because of the illness…the
infertility issues, life span issues, what lupus can and can’t do to
you…and we did–I did, have her with a counselor to help with
dealing with this whole illness in a teenage life on top of a







In treatment at initial study; on psychotropic medication
managed by PCP; irregular therapist visits; persistent
depression & anxiety; history of ODD &ADHD (2.5 years)
“Well, I mean, she was seeing a psychiatrist, like I said. She
didn’t want to get up and she don’t want to go. So she been
seeing a psychiatrist since she was like about four or five…she
hasn’t been keeping appointments. So her primary care
prescribes the Abilify and the Concerta for her. She was




Negative Concealed depression and anxiety symptoms on initial
screen; subsequent suicide attempt & inpatient psychiatric
hospitalization; on psychotropic medication and in
psychotherapy at time of interview (2.0 years)
“At the time, my parents didn’t know what I was feeling, going
through, so I may have like said feelings sad, maybe
sometimes, not all of the time… it’s been like almost two years,
depression, anxiety … I see a therapist. I don’t see how talking
helps, but everybody else says it does, so I try to.” Youth
“As she’s getting older, she’s developing different kinds of
feelings about having an illness that she needs to always think
about, it’s part of her now…trying to interpret her and her
emotions and it’s very hard.” Parent
18 y/o
Female
Negative New anxiety; symptoms minimized by PCP; self-referral to
counselor on advice of family friend; undergoing cognitive
behavioral therapy (1.9 years)
“I have been seeing my psychologist for anxiety for the past, I
think six months or so. I started seeing a psychologist for
cognitive brain therapy” Youth
“She’s had some anxiety this year… and she expressed that to
me…fears of being in a crowd, somebody could do harm, fears
of being alone, fears that something could happen to me, if I




Negative “I get anxiety and I get stressed a lot. I’m a worrier. So that’s it,
it affects my health.” Youth
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of their symptoms by the PCP, resulting in self-referral to
a psychologist on advice from a family friend.
About half of youth with a mental health history had
uncertainty about whether their symptoms warranted
pursuing mental healthcare, often expressing fear and
shame about their emotions, stigmatized by their
feelings and hoping that they would just resolve with
time. Of the youth that did not seek treatment, the most
common reason both youth and their parents gave was
that the symptoms didn’t seem severe enough, despite a
mental health referral by their rheumatologist. Yet five
of the six youth (83 %) initially screening positive had
persistent or additional symptoms by the time of inter-
view. One youth, who admittedly concealed her emo-
tional distress at the time of initial screening, had
subsequent inpatient psychiatric hospitalization for sui-
cidal attempt as her first mental healthcare.
Symptomatic youth receiving mental health treatment
increased from 2 out of 6 (33 %) at initial screening to 6
out of 9 (67 %) at follow-up interview, over a follow-up
time range of 1.6 to 2.5 years. Participants in the care of
psychologists and psychiatrists described challenges in
accessing mental healthcare due to limited availability of
mental health professionals, insurance coverage restrict-
ing choice of clinicians, high copays, and inconvenience
and costs of travel. However, these initial barriers were
usually overcome, and parents were willing to accept the
inconvenience and costs due to the necessity for ser-
vices. Several other youth were taking psychotropic
medications managed by their PCP, and were receiving
counseling through their school, which was viewed as
convenient and affordable. Several parents described
wanting to further help their children themselves, but
felt ill-equipped due to lack of knowledge about mental
health and their own emotional burden.
Discussion
Depression, anxiety and other mental disorders are
prevalent in pediatric SLE/MCTD [2–4], and may lead
to adverse clinical and psychosocial outcomes [10–12],
but these conditions are under-recognized and under-
treated in affected youth [5]. Our qualitative study pro-
vides an in-depth analysis of mental healthcare for youth
with SLE/MCTD from the patient and parent perspective,
adding to the sparse literature in this area. Our results
suggest that youth with SLE/MCTD and their parents per-
ceive mental health as an essential component of overall
health, and that pediatric rheumatology is an acceptable
and preferred setting for mental health screening and
referral to treatment. We identify several barriers and fa-
cilitators for youth and families for identification and
treatment of mental health problems, providing insight to
guide interventions that may improve mental healthcare
for affected youth with SLE/MCTD. Despite limited exter-
nal validity of our results, derived from a small atypical
sample of youth (English-speaking, highly educated and
mostly White) compared to the larger pediatric SLE/
MCTD population, our sample size was adequate to
achieve thematic saturation of pertinent qualitative
themes (the point at which no new themes are emerging)
[32] as a starting point to understanding the youth and
parent perspective on mental healthcare.
Our findings support cited factors associated with un-
met mental healthcare needs such as stigma and those
related to access to care [33], but we also identify previ-
ously unreported factors that pertain more specifically to
youth with SLE/MCTD in subspecialty care. Although
recent efforts have focused on augmenting the role of
PCPs in delivering mental healthcare to adolescents [17],
most of our participants viewed rheumatologists as their
primary doctors, identifying them as a preferred first
healthcare contact for mental health issues. This was at-
tributed to the strong relationship of youth and parents
with rheumatologists due to frequent visits and their re-
liance on them to interpret symptoms in the context of
a highly complex disease. These findings suggest that,
from the perspective of families, rheumatologists have a
significant opportunity to facilitate their mental health
diagnosis and referral.
Most of our sample of youth and parents wanted rheu-
matologists to ask about mental health, viewing it as a
sign of optimal and comprehensive patient care. Yet, the
fact that several youth were reluctant to discuss their
emotions due to fear and shame points to the potential
benefit for medical doctors to “normalize” mental health
evaluation by making it a regular part of care. One way
to achieve this is to administer mental health screening
questionnaires to all youth with SLE/MCTD. In this
study we found that screening youth with SLE/MCTD
using electronic administration of validated screening
tools in the outpatient pediatric rheumatology setting
was acceptable to youth and parents. The screening
process increased youth and parents’ willingness to dis-
cuss mental health issues, a benefit reported for mental
Table 4 Symptom and treatment status of youth with SLE/MCTD and a mental health history (N = 9) (Continued)
New anxiety; referred to mental professional by
rheumatologist; did not seek further evaluation or treatment
(2.0 years)
“Emotionally, she’s a strong kid…she gets a little depressed…
sometimes she can be a worrier. Every now and then, she’ll dip
down and feel a little down, but she usually comes back to the
top. It hasn’t bothered her to the point …where she’s sleeping
all the time, but you can tell when she’s not feeling well” Parent
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health screening in other settings [34]. Screening also
raised the awareness of potential mental health prob-
lems in SLE/MCTD, whether due to central nervous
system disease or psychosocial distress. Although a
few parents raised concerns about mental health
evaluation being overwhelming too soon after diagno-
sis, most desired more education about potential
mental health issues early in the disease process.
These findings suggest that adolescents with SLE/
MCTD may benefit from routine mental health
screening in pediatric rheumatology, and that clini-
cians should be prepared to provide mental health re-
sources to support youth and their families from the
time of diagnosis.
Screening in itself, however, did not appear to be
enough to de-stigmatize mental health issues. There
emerged a clear value of in-person mental health assess-
ment to create an environment conducive to discussing
mental health issues, putting the screening results into
context and identifying hidden feelings of self-harm. The
facilitating factors that we identified suggest that
pediatric rheumatologists can best create this environ-
ment by taking the initiative to begin these conversa-
tions, expressing sincere interest in mental well-being,
taking mental health concerns seriously and facilitating
the initial connection with mental health professionals.
Additionally obtaining a family mental health history
may help normalize mental health for patients and fam-
ilies as well as assess risk for youth; we did not address
this possibility, but future studies could explore this
potential effect. Given the high prevalence of suicidal
ideation in our small sample and other cohorts of youth
with SLE [5, 35], pediatric rheumatologists may have an
opportunity to help youth avoid self-harm and disruptive
inpatient psychiatric stays. Rheumatologists, however,
may need additional mental health training and re-
sources to effect an environment in which mental
health is a usual part of care. Implementation of
routine mental health assessment requires training of
staff and integration into the clinician workflow.
Encouragingly, this has been achieved in other pediatric
subspecialty settings such as endocrinology for type 1
diabetes patients [36].
A major strength of our study is the detailed follow-up
of a sample of youth with SLE/MCTD and mental health
symptoms, providing insight into the factors influencing
their receipt of mental healthcare. While our purposive
sampling strategy may over-represent those with psycho-
social challenges, the prevalence of mental health symp-
toms in our qualitative sample is similar to other studies
[2, 5, 37], and our study design allowed in-depth
characterization of those with mental health problems
who would likely be otherwise under-represented due to
selection bias. We are encouraged that symptomatic
youth receiving mental health treatment increased from
33 % at initial screening to 67 % at follow-up interview.
We speculate that this may be due to enhanced symp-
tom identification through formal screening in the previ-
ous study, increased engagement in addressing mental
health issues among rheumatologists caring for partici-
pants, and heightened awareness of mental health
among participants, leading to increased receptiveness
to rheumatologists helping with mental health issues.
This underscores the opportunity for rheumatologists to
help improve identification of mental health problems
for affected youth.
Nevertheless, several symptomatic youth experienced
delays in mental health treatment due to minimization
of their symptoms by themselves, their parents and clini-
cians, emphasizing the need for educational resources
for patients, families and clinicians. Importantly, increas-
ing awareness of youth and families about the potential
for neuropsychiatric manifestations of SLE to occur
throughout the disease course [38], as well as the high
occurrence of co-morbid mental disorders, may facilitate
youth and parent reporting of mental symptoms. Yet it
should be noted that symptom minimization and other
identified barriers to mental health treatment for youth
with SLE/MCTD, such limited availability and high costs
of mental health services, are likely similar for youth
with other chronic disease in subspecialty care. This
supports a general need for healthcare systems to facili-
tate comprehensive care of such patients by integration
of medical and mental healthcare. With the growing evi-
dence for efficacy of collaborative care models [17, 39],
co-locating mental health professionals with pediatric
rheumatology and other subspecialists may alleviate the
current challenges to mental health treatment.
Care delivery through these models requires significant
support from healthcare systems and institutions,
however, which is difficult to obtain for pediatric rheu-
matologists who are small in number due to limited a
workforce [40]. Therefore collaborative care models, al-
though a promising strategy for mental healthcare of
youth with SLE/MCTD, are not currently feasible for all
pediatric rheumatology settings. While efforts should be
made by pediatric rheumatologists to advocate for med-
ical and mental healthcare integration, other options
should be explored. For example, several youth receiving
school-based counseling and management of psycho-
tropic medications through their PCPs found these alter-
natives to be convenient and cost-effective. Improved
communication and care coordination between rheuma-
tologists, PCPs and mental health providers is likely to
help ensure that treatment is available. More research is
needed to determine the optimal strategies for effective
and accessible mental health treatment for youth with
SLE/MCTD.
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Conclusion
Youth with SLE/MCTD and their parents perceive
pediatric rheumatologists as a preferred source for men-
tal health screening, guidance and referral. Routine men-
tal health screening and clinician-initiated discussion of
mental health may facilitate identification of youth with
mental disorders. Further research is needed to imple-
ment interventions that address barriers and enhance fa-
cilitators to improve mental healthcare for youth with
SLE/MCTD.
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